Healthcare -
Biotechnology - NASDAQ - US
$ 14.24
0.636 %
$ 1.16 B
Market Cap
-4.25
P/E
VRDN - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities VRDN - Viridian Therapeutics, Inc.
-229 M
LAST VALUE
-40.93%
2 YEAR CAGR
-55.53%
5 YEAR CAGR
-95.95%
10 YEAR CAGR